Flow Traders U.S.’s GSK GSK Stock Holding History

Flow Traders U.S.’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35M	Buy	25,703 +9,615	+60%	+$509K	0.06%	333
2026 Q1	$888K	Sell	16,088 -11,449	-42%	-$620K	0.03%	494
2025 Q4	$1.35M	Buy	+27,537	New	+$1.28M	0.04%	300
2024 Q3	–	Sell	-11,857	Closed	-$456K	–	995
2024 Q2	$456K	Buy	+11,857	New	+$499K	0.02%	566
2023 Q4	–	Sell	-10,667	Closed	-$387K	–	924
2023 Q3	$387K	Buy	+10,667	New	+$379K	0.02%	546
2013 Q4	–	Sell	-226,130	Closed	-$14.2M	–	240
2013 Q3	$14.2M	Buy	+226,130	New	+$14.6M	2.24%	9

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Flow Traders U.S.'s GSK Position: Q2 2026 in Review

Flow Traders U.S. increased its GSK (GSK) stake by 60% in Q2 2026, buying an estimated $509K and bringing the position to 25,703 shares worth $1.35M. The position accounts for 0.06% of the portfolio, ranked #333.

Flow Traders U.S. first reported a position in GSK in Q3 2013 and has held it in 6 quarters since. The position peaked at $14.2M in Q3 2013. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Flow Traders U.S. held 25,703 shares of GSK worth $1.35M as of Q2 2026.
Flow Traders U.S. bought 9,615 GSK shares in Q2 2026, an estimated $509K.
GSK made up 0.06% of Flow Traders U.S.'s portfolio in Q2 2026, its #333 holding.
Flow Traders U.S. first reported a position in GSK in Q3 2013 and has held it in 6 quarters since.
Flow Traders U.S.'s GSK position peaked at $14.2M in Q3 2013.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.